Announcement on the Subsidiary's Drug Passing Consistency Evaluation of Generic Drug

About this update from Shanghai Haixin Group Co., Ltd. Class A

Announcement on the Subsidiary's Drug Passing Consistency Evaluation of Generic Drug The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Haixin Group Co., Ltd. Class A